Cargando…
Sirtuin 7: a new marker of aggressiveness in prostate cancer
Predictive biomarkers for advanced prostate cancer (PCa) are still missing. The sirtuin 7 (SIRT7) has been linked to tumorogenesis but its role in prostate cancer is poorly documented. To determine if SIRT7 can be a biomarker for aggressive prostate cancer and plays a role in PCa aggressiveness. We...
Autores principales: | Haider, Romain, Massa, Fabienne, Kaminski, Lisa, Clavel, Stephan, Djabari, Zied, Robert, Guillaume, Laurent, Kathiane, Michiels, Jean-François, Durand, Matthieu, Ricci, Jean-Ehrland, Tanti, Jean-François, Bost, Frédéric, Ambrosetti, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652781/ https://www.ncbi.nlm.nih.gov/pubmed/29100388 http://dx.doi.org/10.18632/oncotarget.20468 |
Ejemplares similares
-
Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
por: Loubière, Camille, et al.
Publicado: (2015) -
The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells
por: Loubiere, Camille, et al.
Publicado: (2017) -
Metformin targets the GTPase Rac1 to inhibit prostate cancer cell migration
por: Dirat, Béatrice, et al.
Publicado: (2014) -
Energy disruptors: rising stars in anticancer therapy?
por: Bost, F, et al.
Publicado: (2016) -
LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes
por: Jing, Lun, et al.
Publicado: (2019)